GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: -2.50 (-13.89%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 16.50
Low: 15.25
Prev. Close: 18.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angle hails study find; Eqtec buys plant in France

Wed, 20th Jul 2022 20:50

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

UK Oil & Gas PLC - exploration and production company focused on UK and Turkey - Says it will need to seek further finance before the middle of the fourth quarter to fund oil exploration in Turkey. The UK energy company says the operator of the Resan licence intends to shoot a new, unbudgeted seismic programme before continuing with the Basur appraisal drilling program. This, combined with a longer than expected seismic acquisition period, has required additional working capital and deferred the start of cash flows from a successful Basur well, UKOG explains. "Given the promising positive outlook derived from the company's Basur Phase 1 seismic programme, plus the confirmation from the oil seep that the area has an active light oil petroleum system, the company's focus for the forthcoming 6-9 months will be firmly upon the delivery of Phase 2 seismic and a new Basur appraisal well, now anticipated to be able to add near-term oil production to the company in H1 2023," it says.

----------

Chariot Ltd - Devon, England-based transitional energy firm focused on Africa - Sees material increase in its gas resources offshore Morocco so it can fast track its field development plans for the Anchois gas project. Anchois sees an 81% rise in high confidence 1C contingent resources to 365 billion cubic feet from 201 billion and a 76% rise in 2C contingent resources to 637 billion cubic feet, whilst prospective resources covering three undrilled targets at Anchois have been estimated at some 754 billion cubic feet. The total remaining recoverable resource at Anchois now stands at 1.4 trillion cubic feet.

----------

San Leon Energy PLC - Dublin-based oil & gas exploration company - Signs new USD16.0 million 4-year loan to ELI Malta with 14% coupon. In addition, San Leon subscribes for further 10% of ELI's diluted share capital.

----------

Angle PLC - Surrey, England-based medical diagnostics company - Notes results of a University of Athens study undertaken in early-stage non-small cell lung cancer. Study demonstrates the benefit of analysing epigenetic alterations in circulating tumour cells to assess patient prognosis. The company’s Parsortix technology was used to isolate circulating tumour cells that provide the tell-tale signs of the disease. "We are pleased to report on the use of the Parsortix system for the isolation of CTCs in early-stage NSCLC, showing potential to enable genetic analysis that provides informative prognostic information. This showcases the potential of liquid biopsy, using the Parsortix system, as a promising tool for the assessment of early-stage disease, which is a key priority for healthcare systems world-wide," says Chief Executive Officer Andrew Newland.

----------

Eqtec PLC - Cork, Ireland-based gasification company focused on turning waste into sustainable energy - Says French subsidiary has acquired and intends to upgrade and recommission a 6.5 megawatt electric waste-to-energy gasification plant in Villers-sous-Montrond, France. The plant is expected to generate a revenue of more than EUR10 million a year and construction work is expected to start in the first quarter of 2023. Eqtec said the plant, which has already received an investment of EUR35 million, will be acquired at nominal value, as the recommissioning will require a further investment of EUR30 million.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
18 Apr 2016 08:48

ANGLE Gets Strong Results From Parsortix Breast Cancer Tests

Read more
21 Mar 2016 14:04

Angle closer to using cassette tech for prostate cancer detection

(ShareCast News) - There was praise for the progress made by Angle on Monday, in its quest to see one of its existing products used as a diagnostic tool for prostate cancer. The AIM-traded company was the subject of a report by equity advisory firm Edison, which said that while the final data was ye

Read more
21 Mar 2016 08:45

ANGLE Gets Good Results On Parsortix System Tests For Prostate Cancer

Read more
9 Mar 2016 10:09

ANGLE Secures European Patent For Parsortix System

Read more
28 Jan 2016 11:11

ANGLE First Half Loss Widens As It Continues Parsortix Development

Read more
25 Jan 2016 09:13

ANGLE Says Parsortix Evaluation Published In Medical Journal

Read more
22 Dec 2015 11:45

Angle Receives GBP700,000 From Geomerics Sale Escrow Release

Read more
15 Dec 2015 08:50

ANGLE Secures First Commercial Sales For Parsortix Research System

Read more
17 Nov 2015 10:56

ANGLE Says "Highly Encouraging" Parsortix Results Published

Read more
14 Oct 2015 09:59

ANGLE Granted Canadian Patent For Parsoritx System

Read more
28 Sep 2015 07:40

ANGLE Sees Further Encouraging Results For Parsortix In Ovarian Cancer

Read more
24 Sep 2015 08:02

ANGLE Says Work With Parsortix In Prostate Cancer Published In Journal

Read more
23 Sep 2015 15:06

AGM, EGM Calendar - Week Ahead

Read more
9 Sep 2015 07:38

ANGLE Says "Highly Promising" Parsortix Breast Cancer Results Presented

Read more
23 Jul 2015 11:23

LONDON MARKET MIDDAY: US Stocks Seen Up Ahead Of Amazon, GM, AT&T

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.